Mp70-07 the Incidence and Mortality of Bladder Cancer in Two Underserved Cities in New Jersey

You have accessJournal of UrologyDiversity, Equity & Inclusion: Health Equity & Outcomes III (MP70)1 May 2024MP70-07 THE INCIDENCE AND MORTALITY OF BLADDER CANCER IN TWO UNDERSERVED CITIES IN NEW JERSEY Samantha Williams, Anh Nguyen, Gabriel Fernandez, Courtney Berg, Rebecca Anderson, Ernest Gillan, Evan Kovac, Amjad Alwaal, and Robert E. Weiss Samantha WilliamsSamantha Williams , Anh NguyenAnh Nguyen , Gabriel FernandezGabriel Fernandez , Courtney BergCourtney Berg , Rebecca AndersonRebecca Anderson , Ernest GillanErnest Gillan , Evan KovacEvan Kovac , Amjad AlwaalAmjad Alwaal , and Robert E. WeissRobert E. Weiss View All Author Informationhttps://doi.org/10.1097/01.JU.0001008796.84999.75.07AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Bladder cancer is a major challenge for the urologic oncologist. In 2023 there were 82,290 new bladder cancer cases in the US. The national incidence between 2015-2019 was 21.9% White, 11.5 African Americans (AA) and 10.7% Hispanic. Despite the lower incidence of bladder cancer in AA, the national 5 year survival with bladder cancer is 82.8% for White patients, 80.7 for Hispanic and 70.2% for AA. The state of New Jersey is ranked 7th in the US in incidence of bladder cancer, even though it is one of the lowest states in per capita cigarette smoking. New Jersey is an extremely diverse state with many ethnic groups – 56% White, 20% Hispanic, 13 % AA. Despite this diversity, NJ does have a history of "redlining" which has created underserved communities with poor educational, economic and medical resources. We investigated the incidence and mortality of bladder cancer in two urban centers – Trenton and Newark, NJ to compare with national findings. METHODS: The NJ State Registry was used to compare bladder cancer incidence and mortality from (2016-2020) and (2011-2015). The date ranges were used due to the overall low numbers of cases per year. The state registry only had partial data for bladder cancer mortality from 2011-2015. We compared the rates from two underserved communities Newark/Essex County and Trenton/ Mercer County. RESULTS: The incidence of bladder cancer in NJ from 2016-2020 was 12,433 patients with age adjusted rate of 22.0/ 100,000. There were 10,987 White (age adjusted 24.1), 792 AA (age adjust 12.0) and 818 Hispanic (age adjust 12.9). During this time period, the incidence of bladder cancer in Newark/Essex County was 528 for Whites, 164 for AA and 74 for Hispanic. Age adjusted rate was 21.6 for Whites, 9.9 for AA and 11.5 for Hispanic. The incidence of bladder cancer in Trenton/Mercer County was 387 White, 55 for AA and 19 for Hispanic. The age adjusted rates were 23.2 for Whites, 14.6 for AA and 12.2 for Hispanics. The bladder cancer incidence for NJ from 2011-2015 was similar with 12,407 patients – age adjusted 28.0/100,000. There were 11,279 White (age adjust 34.2), 731 AA (age adjust 12.7) and 750 Hispanic (age adjust 15.1). During this time period, the incidence of bladder cancer in Newark/Essex was 598 White, 156 AA, 19 Hispanic. The age adjusted rates were 25.2 White, 10.5 AA and 17.0 Hispanic. The incidence of bladder cancer in Trenton/Mercer County was 391 White, 52 AA, 19 Hispanic. The age adjusted rates were 24.6 White, 15.4 AA and 14.3 Hispanic. The bladder cancer mortality rate for NJ from 2016-2020 was 2,513 patients with age adjusted rate of 4.4. During this time period, the mortality in Newark/Essex was 106 White (age adjust 4.0) 42 AA (age adjust 2.5). The mortality for Trenton/Mercer was 86 White (age adjust 4.9) and 14 AA (age adjust 3.9). The bladder cancer mortality in NJ from 2011-2015 was 2,514 with age adjusted rate of 4.8. During this period, mortality in Newark/Essex was 105 White (age adjust 4.2), 43 AA (age adjust 3.1). The mortality for Trenton/Mercer White 87 (age adjust 5.2), AA not reported. CONCLUSIONS: Our data from two underserved NJ cities mirrors the national data regarding the difference in the incidence of bladder cancer in Whites and AA. We found that despite limited health care resources and access, NJ AA patients have lower age adjusted mortality compared to white patients. Differences in cigarette consumption, environmental factors and genetic factors may affect bladder cancer incidence and warrants further study. Source of Funding: None © 2024 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 211Issue 5SMay 2024Page: e1131 Advertisement Copyright & Permissions© 2024 by American Urological Association Education and Research, Inc.Metrics Author Information Samantha Williams More articles by this author Anh Nguyen More articles by this author Gabriel Fernandez More articles by this author Courtney Berg More articles by this author Rebecca Anderson More articles by this author Ernest Gillan More articles by this author Evan Kovac More articles by this author Amjad Alwaal More articles by this author Robert E. Weiss More articles by this author Expand All Advertisement PDF downloadLoading ...